825 related articles for article (PubMed ID: 33944850)
1. Efficacy and safety of lacosamide in the treatment of status epilepticus in a patient with comorbidities.
Mascolo AP; Marrama F; Mercuri NB; Placidi F
Acta Biomed; 2021 Apr; 92(S1):e2021090. PubMed ID: 33944850
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
[TBL] [Abstract][Full Text] [Related]
3. Observational study of intravenous lacosamide in patients with convulsive versus non-convulsive status epilepticus.
Moreno Morales EY; Fernandez Peleteiro M; Bondy Peña EC; Domínguez Lorenzo JM; Pardellas Santiago E; Fernández A
Clin Drug Investig; 2015 Jul; 35(7):463-9. PubMed ID: 26108190
[TBL] [Abstract][Full Text] [Related]
4. Tonic status epilepticus in a centenarian woman.
Fernández-Torre JL; Riancho J; Martín-García M; Martínez-de Las Cuevas G; Bosque-Varela P
Epileptic Disord; 2019 Feb; 21(1):92-96. PubMed ID: 30816845
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: A systematic review.
Ortiz de la Rosa JS; Ladino LD; Rodríguez PJ; Rueda MC; Polanía JP; Castañeda AC
Seizure; 2018 Mar; 56():34-40. PubMed ID: 29428899
[TBL] [Abstract][Full Text] [Related]
6. Intravenous lacosamide for treatment of absence status epilepticus in genetic generalized epilepsy: A case report and review of literature.
Reif PS; Männer A; Willems LM; Kay L; Zöllner JP; Klein KM; Rosenow F; Strzelczyk A
Acta Neurol Scand; 2018 Sep; 138(3):259-262. PubMed ID: 29633241
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of lacosamide in neonatal-onset super-refractory status epilepticus: a case report.
Bertozzi V; Bonardi CM; Biscalchin G; Tona C; Amigoni A; Sartori S
Epileptic Disord; 2021 Aug; 23(4):655-660. PubMed ID: 34259154
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.
Tilz C; Resch R; Hofer T; Eggers C
Epilepsia; 2010 Feb; 51(2):316-7. PubMed ID: 19674050
[TBL] [Abstract][Full Text] [Related]
9. Intravenous Lacosamide in Pediatric Status Epilepticus: An Open-Label Efficacy and Safety Study.
Poddar K; Sharma R; Ng YT
Pediatr Neurol; 2016 Aug; 61():83-6. PubMed ID: 27241232
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.
Sutter R; Marsch S; Rüegg S
CNS Drugs; 2013 Apr; 27(4):321-9. PubMed ID: 23533010
[TBL] [Abstract][Full Text] [Related]
11. The use of lacosamide in refractory status epilepticus.
Goodwin H; Hinson HE; Shermock KM; Karanjia N; Lewin JJ
Neurocrit Care; 2011 Jun; 14(3):348-53. PubMed ID: 21249530
[TBL] [Abstract][Full Text] [Related]
12. A Rare Case of Prolonged Ictal Aphasia.
Katyal R; De Sousa E; Sultan F
Neurodiagn J; 2019; 59(2):104-111. PubMed ID: 31210608
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Antiepileptic Approaches in Treatment of Benzodiazepine Nonresponsive Status Epilepticus.
Bachhuber A; Lasrich M; Halmer R; Fassbender K; Walter S
CNS Neurosci Ther; 2016 Mar; 22(3):178-83. PubMed ID: 26841716
[TBL] [Abstract][Full Text] [Related]
14. Super-refractory nonconvulsive status epilepticus secondary to fat embolism: A clinical, electrophysiological, and pathological study.
Fernández-Torre JL; Burgueño P; Ballesteros MA; Hernández-Hernández MA; Villagrá-Terán N; de Lucas EM
Epilepsy Behav; 2015 Aug; 49():184-8. PubMed ID: 25986321
[TBL] [Abstract][Full Text] [Related]
15. Absence status induced by lacosamide adjunctive therapy.
Ákos Szabó C; Morgan LC; Sonnenberg S; Karkar KM
Epileptic Disord; 2019 Feb; 21(1):97-101. PubMed ID: 30782579
[TBL] [Abstract][Full Text] [Related]
16. Intravenous lacosamide--an effective add-on treatment of refractory status epilepticus.
Albers JM; Möddel G; Dittrich R; Steidl C; Suntrup S; Ringelstein EB; Dziewas R
Seizure; 2011 Jun; 20(5):428-30. PubMed ID: 21354831
[TBL] [Abstract][Full Text] [Related]
17. [Paediatric status epilepticus].
Soto-Insuga V; González-Alguacil E; García-Peñas JJ
Rev Neurol; 2022 Oct; 75(8):225-238. PubMed ID: 36218253
[TBL] [Abstract][Full Text] [Related]
18. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD
Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679
[TBL] [Abstract][Full Text] [Related]
19. Subacute encephalopathy and seizures in alcoholics (SESA) presenting with non-convulsive status epilepticus.
LaRoche SM; Shivdat-Nanhoe R
Seizure; 2011 Jul; 20(6):505-8. PubMed ID: 21459625
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of refractory simple motor status epilepticus with lacosamide and levetiracetam.
Chen LL; Haneef Z; Dorsch A; Keselman I; Stern JM
Seizure; 2011 Apr; 20(3):263-5. PubMed ID: 21109468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
